Duong David T, Parekh Dipen J, Pope John C, Adams Mark C, Brock John W
Department of Urologic Survey, Vanderbilt Children's Hospital, Nashville, Tennessee 37232, USA.
J Urol. 2003 Oct;170(4 Pt 2):1570-3; discussion 1573. doi: 10.1097/01.ju.0000084144.50541.3d.
We determine whether routinely performing catheterless ureteroneocystostomy would minimize hospital stays without compromising postoperative outcomes.
Between May 1996 and February 2002 patients who underwent ureteroneocystostomy at a single major tertiary care institution were identified. Patients who underwent additional, simultaneous surgical procedures were excluded from the study. Data recorded included patient demographics, reflux grade, use of a bladder catheter, length of hospital stay, medication use, postoperative complications and subsequent rehospitalization.
Of the 300 patients included in the study 266 were girls and 34 were boys, with a median age of 4 years (range 3 months to 19 years). Reimplantation was bilateral in 215 cases and unilateral in 85. Reflux was grade I in 1% of cases, grade II in 18%, grade III in 47%, grade IV in 25% and grade V in 9%. Similar distributions were observed among the 76 patients who received bladder catheters and the 224 who did not. The average length of postoperative hospitalization for patients who received catheters compared to those who did not was 2.1 versus 1.4 days (p <0.001), and the rate of prolonged hospitalization are 18% versus 5%, respectively (p <0.01). Postoperative complication rates were 17% versus 8% (p <0.05) for patients who received catheters compared to those who did not. There was no statistically significant difference in the rate of rehospitalization whether urethral catheters were used (1.3% vs 4.9%, respectively, p = 0.07). Furthermore, there was no statistically significant difference in the amount of either ketorolac or oxybutynin used by patients who received catheters compared to those who did not.
Surgical repair of vesicoureteral reflux via catheterless ureteroneocystostomy can reduce hospital stay without adversely affecting complication rates, rehospitalization rates and the amount of medications needed postoperatively.
我们确定常规进行无导管输尿管膀胱吻合术是否能在不影响术后结果的情况下使住院时间最短。
确定1996年5月至2002年2月期间在一家大型三级医疗中心接受输尿管膀胱吻合术的患者。接受额外同期手术的患者被排除在研究之外。记录的数据包括患者人口统计学资料、反流分级、膀胱导管的使用、住院时间、药物使用、术后并发症及随后的再次住院情况。
研究纳入的300例患者中,266例为女孩,34例为男孩,中位年龄4岁(范围3个月至19岁)。双侧再植215例,单侧85例。1%的病例反流为I级,18%为II级,47%为III级,25%为IV级,9%为V级。在接受膀胱导管的76例患者和未接受膀胱导管的224例患者中观察到相似的分布。接受导管的患者与未接受导管的患者相比,术后平均住院时间分别为2.1天和1.4天(p<0.001),延长住院率分别为18%和5%(p<0.01)。接受导管的患者与未接受导管的患者相比,术后并发症发生率分别为17%和8%(p<0.05)。无论是否使用尿道导管,再次住院率均无统计学显著差异(分别为1.3%和4.9%,p = 0.07)。此外,接受导管的患者与未接受导管的患者相比,酮咯酸或奥昔布宁的使用量均无统计学显著差异。
通过无导管输尿管膀胱吻合术进行膀胱输尿管反流的手术修复可缩短住院时间,且不会对并发症发生率、再次住院率及术后所需药物量产生不利影响。